Stockwatch: Will Coronavirus Drug Developments Rescue The Sector’s Pricing Reputation?
Mid-Year Drug Price Increases Threaten Biopharma's Coronavirus Reputation Boost
Can the development of coronavirus vaccines and therapeutics reverse the demonization of the pharmaceutical sector brought about by drug price increases?
